- Home
- GSK vs ITUB Comparison
GSK vs ITUB Comparison
Compare GSK & ITUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GSK
- ITUB
- Stock Information
- Founded
- GSK 1715
- ITUB 1924
- Country
- GSK United Kingdom
- ITUB Brazil
- Employees
- GSK N/A
- ITUB N/A
- Industry
- GSK Biotechnology: Pharmaceutical Preparations
- ITUB Major Banks
- Sector
- GSK Health Care
- ITUB Finance
- Exchange
- GSK Nasdaq
- ITUB Nasdaq
- Market Cap
- GSK 93.1B
- ITUB 81.3B
- IPO Year
- GSK N/A
- ITUB N/A
- Fundamental
- Price
- GSK $47.66
- ITUB $7.42
- Analyst Decision
- GSK Strong Buy
- ITUB Buy
- Analyst Count
- GSK 1
- ITUB 3
- Target Price
- GSK N/A
- ITUB $7.09
- AVG Volume (30 Days)
- GSK 5.4M
- ITUB 19.7M
- Earning Date
- GSK 10-29-2025
- ITUB 11-04-2025
- Dividend Yield
- GSK 3.49%
- ITUB 5.74%
- EPS Growth
- GSK 118.57
- ITUB 13.27
- EPS
- GSK 1.79
- ITUB 0.77
- Revenue
- GSK $43,237,357,842.00
- ITUB $25,400,232,630.00
- Revenue This Year
- GSK $6.08
- ITUB $39.44
- Revenue Next Year
- GSK $5.22
- ITUB $6.73
- P/E Ratio
- GSK $26.62
- ITUB $9.67
- Revenue Growth
- GSK 2.73
- ITUB N/A
- 52 Week Low
- GSK $31.72
- ITUB $4.42
- 52 Week High
- GSK $48.69
- ITUB $7.86
- Technical
- Relative Strength Index (RSI)
- GSK 60.77
- ITUB 51.79
- Support Level
- GSK $45.81
- ITUB $7.32
- Resistance Level
- GSK $47.98
- ITUB $7.47
- Average True Range (ATR)
- GSK 0.65
- ITUB 0.13
- MACD
- GSK -0.19
- ITUB -0.04
- Stochastic Oscillator
- GSK 64.06
- ITUB 19.44
About GSK GSK plc (Each representing two)
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
About ITUB Itau Unibanco Banco Holding SA (Each repstg 500 Preferred shares)
Itaú Unibanco is the largest privately held bank in Brazil, the result of the 2008 merger between Banco Itaú and Unibanco. In addition to Brazil, the bank has significant operations in Chile, Colombia, Argentina, Uruguay, and Paraguay. Itaú's commercial and consumer loans account for 35% and 43% of the bank's total loans, respectively, while foreign loans account for 22% of its portfolio. The bank also operates the fifth-largest insurer in Brazil and is the second-largest asset manager in the country, giving it broad reach over the Brazilian financial system.